![Peter G. Abram](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Peter G. Abram
Director of Finance/CFO at MDS Pharma Services (Canada)
Profile
Peter G.
Abram is currently the Chief Financial Officer & Senior Vice President at MDS Pharma Services (Canada) since 2005.
Prior to this, he worked as a Manager-Financial Planning & Reporting at General Electric Co. He also served as the Chief Financial Officer & Senior Vice President at FARO Technologies, Inc. from 2014 to 2015.
Mr. Abram completed his undergraduate degree from Miami University.
Peter G. Abram active positions
Companies | Position | Start |
---|---|---|
MDS Pharma Services (Canada)
![]() MDS Pharma Services (Canada) Miscellaneous Commercial ServicesCommercial Services MDS Pharma Services provides contract drug discovery and drug development services for pharmaceutical and biotechnology companies. It provides its clients with early-stage, clinical research and late-stage drug discovery and development services, such as Phase I-IV testing, target discovery and lead optimization. The company is located in Saint-Laurent, Canada. | Director of Finance/CFO | 2005-09-05 |
Former positions of Peter G. Abram
Companies | Position | End |
---|---|---|
FARO TECHNOLOGIES, INC. | Director of Finance/CFO | 2015-03-19 |
GE AEROSPACE | Corporate Officer/Principal | - |
Training of Peter G. Abram
Miami University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
GE AEROSPACE | Producer Manufacturing |
FARO TECHNOLOGIES, INC. | Electronic Technology |
Private companies | 1 |
---|---|
MDS Pharma Services (Canada)
![]() MDS Pharma Services (Canada) Miscellaneous Commercial ServicesCommercial Services MDS Pharma Services provides contract drug discovery and drug development services for pharmaceutical and biotechnology companies. It provides its clients with early-stage, clinical research and late-stage drug discovery and development services, such as Phase I-IV testing, target discovery and lead optimization. The company is located in Saint-Laurent, Canada. | Commercial Services |
- Stock Market
- Insiders
- Peter G. Abram